Introduction
PursueCare, a leader in virtual addiction treatment, has relaunched RESET and RESET-O, two FDA-cleared prescription digital therapeutics (PDTs), designed to help individuals struggling with substance use disorder (SUD) and opioid use disorder (OUD). Originally…
PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics for substance use disorder and opioid use disorder.RESET and RESET-O were initially developed and…
Continue Reading
Otsuka Precision Health, a prescription digital therapeutics company, and Amalgam Rx, a holdings company in the pharmaceutical and nutraceutical market, have launched Elevmi, a digital application designed to help caregivers assist family members who…
Continue Reading
Otsuka Precision Health, a prescription digital therapeutics company, and Amalgam Rx, a holdings company in the pharmaceutical and nutraceutical market, have launched Elevmi, a digital application designed to help caregivers assist family members who…
Continue Reading
DarioHealth, a digital chronic-condition-management platform, announced it entered into a new contract with a national Medicare Advantage health plan and plans to launch its behavioral health initiative, Twill by Dario, for the plan’s members in…
Continue Reading
Welcome to the August edition of Digital Health Digest!This month, we're covering exciting developments from new venture investments in digital health to significant regulatory updates that shape the future of healthcare technology and AI…
Continue Reading
Digital therapeutics have significantly improved access to care for many patients, while delivering consistent clinical outcomes across a wide range of conditions. However, despite the potential these new treatments offer, convincing payers to embrace…
Continue Reading
When the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for…
Continue Reading
Andy Molnar, CEO of the Digital Therapeutics Alliance, has been selected as an industry representative for the FDA’s Digital Health Advisory Committee (DHAC). The FDA established the DHAC to ensure safe and effective regulation of…
Continue Reading
The Royal Hospital for Children in Glasgow is trailing a wireless device which could help help diagnose respiratory and sleep conditions in babies and young children.
The early-stage study will monitor 75 infants from the…
